Marsh(MRSH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 22.84 | EPS (ttm) | 8.35 | Insider Own | 0.1% | Shs Outstand | 475.4M | Perf Week | -0.31% |
| Market Cap | 90.67B | Forward P/E | 16.64 | EPS next Y | 9.3% | Insider Trans | -12.23% | Shs Float | 475.1M | Perf Month | 12.8% |
| Enterprise Value | 111.39B | PEG | 1.88 | EPS next Q | 2.22 | Inst Own | 94.95% | Short Float | 1.42% | Perf Quarter | -3.5% |
| Income | 4.04B | P/S | 3.18 | EPS this Y | 7.53% | Inst Trans | -2.06% | Short Ratio | 2.69 | Perf Half Y | 11.62% |
| Sales | 28.48B | P/B | 6.18 | EPS next 5Y | 8.87% | ROA | 6.82% | Short Interest | 6.76M | Perf YTD | 2.78% |
| Book/sh | 30.87 | P/C | 49.22 | EPS past 3/5Y | 11.72% 16.42% | ROE | 27.1% | 52W High | -4.82% ($200.32) | Perf Year | 1.63% |
| Cash/sh | 3.87 | P/FCF | 21.83 | Sales past 3/5Y | 9.12% 9.45% | ROIC | 11.53% | 52W Low | 21.76% ($156.60) | Perf 3Y | 3.12% |
| Dividend Est. | $3.79 (1.99%) | EV/EBITDA | 14.42 | EPS Y/Y TTM | -0.07% | Gross Margin | - | Volatility(W/M) | 2.39% 2.15% | Perf 5Y | 13.74% |
| Dividend TTM | 3.78 | EV/Sales | 3.91 | Sales Y/Y TTM | 7.64% | Oper. Margin | 23.92% | ATR (14) | 4.32 | Perf 10Y | 201.79% |
| Dividend Ex-Date | 2026/10/1 | Quick Ratio | 1.09 | EPS Q/Q | 11.55% | Profit Margin | 14.19% | RSI (14) | 60.63 | Recom | 2.61 |
| Dividend Gr. 3/5Y | 15.07% 13.73% | Current Ratio | 1.09 | Sales Q/Q | 7.93% | SMA20 | 4.76% ($182.01) | Beta | 0.54 | Target Price | $204.76 |
| Payout | 41.74% | Debt/Eq | 1.52 | Earnings | 2026/10/15 | SMA50 | 4.84% ($181.87) | Rel Volume | 0.82 | Prev Close | $194.72 |
| Employees | 95000 | LT Debt/Eq | 1.39 | EPS/Sales Surpr. | 3.13% 3.29% | SMA200 | 7.73% ($176.99) | Avg Volume(3M) | 2.51M | Price | $190.67 |
| IPO | 1968/2/19 | Option/Short | Yes/Yes | Trades | 22042 | Volume | 2,064,610 | Change | -2.08% |
🛡️ This insurance brokerage company provides global insurance brokerage and risk management consulting services. It operates consulting and brokerage services across the entire insurance value chain—including corporate risk assessment, insurance underwriting placement, claims processing, and risk management advisory—in multiple regions around the world.
Over the past 1 year, on the higher side
5% below its 1-year high.
Traded about as much as usual. That is 82% of its average volume.
MRSH makes money exceptionally well
Of every $100 in sales, $23.92 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +7.5% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,442. Peers typically go for $1,365. Compared with its own 5-year average, it is 11% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Long-term returns are roughly flat
Bought 5 years ago, your return today would be +13.7%. The S&P 500 did +70% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.99% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 95.0%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It is the largest in the industry
Based on market cap of $91B.
FAQ
What kind of company is MRSH?
MRSH belongs to the Financial sector and operates in the Insurance Brokers industry.
What is the market cap of MRSH?
The market cap of MRSH is approximately $90.7B, ranking 185 within its sector.
Does MRSH pay dividends?
MRSH has a dividend yield of approximately 1.99%, with an annual dividend of $3.79.
What is the P/E ratio of MRSH?
MRSH has a P/E ratio of approximately 22.8x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for MRSH?
MRSH has recorded a 52-week high of $200.32 and a low of $156.60.